The groundbreaking rise of Viagra has firmly established as a symbol of pharmaceutical success, but its legacy within the broader market now presents questions about potential yields . Alternative versions are diminishing exclusivity , causing worries that supporting companies significantly dependent to Viagra's previous standing could be a problem